As in prior studies, we found that MTX use without folic acid was positively associated with the risk of ALT elevation [34]; however, no study has compared the risk of MTX-related hepatitis in anti-TNF users with differing HBV infection status. This evidence concerns the gene TNF and hepatitis A virus infection.